| Year |
Citation |
Score |
| 2023 |
Zhang T, Gephart SM, Subbian V, Boyce RD, Villa-Zapata L, Tan MS, Horn J, Gomez-Lumbreras A, Romero AV, Malone DC. Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support. Applied Clinical Informatics. 14: 779-788. PMID 37793617 DOI: 10.1055/s-0043-1772686 |
0.48 |
|
| 2023 |
Stottlemyer BA, McDermott MC, Minogue MR, Gray MP, Boyce RD, Kane-Gill SL. Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study. Therapeutic Advances in Drug Safety. 14: 20420986231181334. PMID 37332887 DOI: 10.1177/20420986231181334 |
0.435 |
|
| 2023 |
Taneja SB, Callahan TJ, Paine MF, Kane-Gill SL, Kilicoglu H, Joachimiak MP, Boyce RD. Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions. Journal of Biomedical Informatics. 140: 104341. PMID 36933632 DOI: 10.1016/j.jbi.2023.104341 |
0.448 |
|
| 2023 |
Li X, Ndungu P, Taneja SB, Chapin MR, Egbert SB, Akenapalli K, Paine MF, Kane-Gill SL, Boyce RD. An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 through September 2021. Clinical and Translational Science. PMID 36861661 DOI: 10.1111/cts.13505 |
0.382 |
|
| 2022 |
Kravchenko OV, Boyce RD, Gomez-Lumbreras A, Kocis PT, Villa Zapata L, Tan M, Leonard CE, Andersen KM, Mehta H, Alexander GC, Malone DC. Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C). Bmj Open. 12: e066846. PMID 36581417 DOI: 10.1136/bmjopen-2022-066846 |
0.337 |
|
| 2022 |
Hansten PD, Tan MS, Horn JR, Gomez-Lumbreras A, Villa-Zapata L, Boyce RD, Subbian V, Romero A, Gephart S, Malone DC. Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug Safety. 1-20. PMID 36522578 DOI: 10.1007/s40264-022-01265-1 |
0.475 |
|
| 2022 |
Malone DC, Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD. Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)". Drug Safety. PMID 36223037 DOI: 10.1007/s40264-022-01239-3 |
0.457 |
|
| 2022 |
Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD, Malone DC. A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS). Drug Safety. PMID 35834155 DOI: 10.1007/s40264-022-01200-4 |
0.359 |
|
| 2022 |
Villa Zapata L, Subbian V, Boyce RD, Hansten PD, Horn JR, Gephart SM, Romero A, Malone DC. Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review. Studies in Health Technology and Informatics. 290: 380-384. PMID 35673040 DOI: 10.3233/SHTI220101 |
0.51 |
|
| 2022 |
Villa Zapata L, Boyce RD, Chou E, Hansten PD, Horn JR, Gephart SM, Subbian V, Romero A, Malone DC. QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data. Drugs - Real World Outcomes. PMID 35665910 DOI: 10.1007/s40801-022-00307-5 |
0.334 |
|
| 2022 |
Reese T, Wright A, Liu S, Boyce R, Romero A, Del Fiol G, Kawamoto K, Malone D. Improving the specificity of drug-drug interaction alerts: Can it be done? American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 35136935 DOI: 10.1093/ajhp/zxac045 |
0.384 |
|
| 2021 |
Reese TJ, Del Fiol G, Morgan K, Hurwitz JT, Kawamoto K, Gomez-Lumbreras A, Brown ML, Thiess H, Vazquez SR, Nelson SD, Boyce R, Malone D. A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study. Jmir Human Factors. 8: e28618. PMID 34698649 DOI: 10.2196/28618 |
0.452 |
|
| 2021 |
Kim H, Pfeiffer CM, Gray MP, Stottlemyer BA, Boyce RD, Kane-Gill SL. Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database. Respiratory Care. PMID 34103383 DOI: 10.4187/respcare.08809 |
0.376 |
|
| 2021 |
Chou E, Boyce RD, Balkan B, Subbian V, Romero A, Hansten PD, Horn JR, Gephart S, Malone DC. Designing and evaluating contextualized drug-drug interaction algorithms. Jamia Open. 4: ooab023. PMID 33763631 DOI: 10.1093/jamiaopen/ooab023 |
0.463 |
|
| 2021 |
Patel NM, Stottlemyer BA, Gray MP, Boyce RD, Kane-Gill SL. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Cardiovascular Drugs and Therapy. PMID 33599896 DOI: 10.1007/s10557-021-07157-3 |
0.357 |
|
| 2020 |
Hoang L, Boyce RD, Bosch N, Stottlemyer B, Brochhausen M, Schneider J. Automatically classifying the evidence type of drug-drug interaction research papers as a step toward computer supported evidence curation. Amia ... Annual Symposium Proceedings. Amia Symposium. 2020: 554-563. PMID 33936429 |
0.455 |
|
| 2020 |
Hochheiser H, Jing X, Garcia EA, Ayvaz S, Sahay R, Dumontier M, Banda JM, Beyan O, Brochhausen M, Draper E, Habiel S, Hassanzadeh O, Herrero-Zazo M, Hocum B, Horn J, ... ... Boyce RD, et al. A Minimal Information Model for Potential Drug-Drug Interactions. Frontiers in Pharmacology. 11: 608068. PMID 33762928 DOI: 10.3389/fphar.2020.608068 |
0.532 |
|
| 2020 |
Birer-Williams C, Gufford BT, Chou E, Alilio M, VanAlstine S, Morley RE, McCune JS, Paine MF, Boyce RD. A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: from Chemical Characterization to Clinical Studies. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 32601103 DOI: 10.1124/Dmd.120.000054 |
0.449 |
|
| 2020 |
Malec SA, Boyce RD. Exploring Novel Computable Knowledge in Structured Drug Product Labels. Amia Joint Summits On Translational Science Proceedings. Amia Joint Summits On Translational Science. 2020: 403-412. PMID 32477661 |
0.346 |
|
| 2020 |
Villa Zapata L, Hansten PD, Panic J, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Risk of Bleeding with Exposure to Warfarin and Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. PMID 32455439 DOI: 10.1055/S-0040-1710592 |
0.526 |
|
| 2020 |
Villa Zapata L, Hansten PD, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. Drug Safety. PMID 32274687 DOI: 10.1007/S40264-020-00930-7 |
0.479 |
|
| 2020 |
Villa Zapata L, Hansten P, Panic J, Horn J, Boyce R, Gephart S, Subbian V, Romero A, Malone D. PGI27 GASTROINTESTINAL BLEEDING WITH CONCOMITANT EXPOSURE TO WARFARIN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A SYSTEMATIC REVIEW AND META-ANALYSIS Value in Health. 23: S147. DOI: 10.1016/J.Jval.2020.04.382 |
0.399 |
|
| 2019 |
Grizzle AJ, Hines LE, Malone DC, Kravchenko O, Hochheiser H, Boyce RD. Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment. Journal of Biomedical Informatics. 103355. PMID 31838211 DOI: 10.1016/J.Jbi.2019.103355 |
0.578 |
|
| 2019 |
Nguyen BP, Reese T, Decker S, Malone D, Boyce RD, Beyan O. Implementation of Clinical Decision Support Services to Detect Potential Drug-Drug Interaction Using Clinical Quality Language. Studies in Health Technology and Informatics. 264: 724-728. PMID 31438019 DOI: 10.3233/Shti190318 |
0.503 |
|
| 2019 |
Grizzle AJ, Horn J, Collins C, Schneider J, Malone DC, Stottlemyer B, Boyce RD. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey. Journal of Medical Internet Research. 21: e11182. PMID 30609981 DOI: 10.2196/11182 |
0.616 |
|
| 2018 |
Boyce RD, Ragueneau-Majlessi I, Yu J, Tay-Sontheimer J, Kinsella C, Chou E, Brochhausen M, Judkins J, Gufford BT, Pinkleton BE, Cooney R, Paine MF, McCune JS. Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for Researchers. Amia ... Annual Symposium Proceedings. Amia Symposium. 2018: 279-287. PMID 30815066 |
0.415 |
|
| 2018 |
Natsiavas P, Boyce RD, Jaulent MC, Koutkias V. : Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies. Frontiers in Pharmacology. 9: 609. PMID 29997499 DOI: 10.3389/Fphar.2018.00609 |
0.372 |
|
| 2018 |
Judkins J, Tay-Sontheimer J, Boyce RD, Brochhausen M. Extending the DIDEO ontology to include entities from the natural product drug interaction domain of discourse. Journal of Biomedical Semantics. 9: 15. PMID 29743102 DOI: 10.1186/S13326-018-0183-Z |
0.58 |
|
| 2018 |
Camacho J, Medina Ch AM, Landis-Lewis Z, Douglas G, Boyce R. Comparing a Mobile Decision Support System Versus the Use of Printed Materials for the Implementation of an Evidence-Based Recommendation: Protocol for a Qualitative Evaluation. Jmir Research Protocols. 7: e105. PMID 29653921 DOI: 10.2196/Resprot.9827 |
0.307 |
|
| 2017 |
Utecht J, Brochhausen M, Judkins J, Schneider J, Boyce RD. Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation. Studies in Health Technology and Informatics. 245: 960-964. PMID 29295242 DOI: 10.3233/978-1-61499-830-3-960 |
0.515 |
|
| 2017 |
Boyce RD, Jao J, Miller T, Kane-Gill SL. Automated Screening of Emergency Department Notes for Drug-Associated Bleeding Adverse Events Occurring in Older Adults. Applied Clinical Informatics. 8: 1022-1030. PMID 29241242 DOI: 10.4338/Aci-2017-02-Ra-0036 |
0.34 |
|
| 2017 |
Romagnoli KM, Nelson SD, Hines L, Empey P, Boyce RD, Hochheiser H. Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews. Bmc Medical Informatics and Decision Making. 17: 21. PMID 28228132 DOI: 10.1186/S12911-017-0419-3 |
0.584 |
|
| 2017 |
Freimuth RR, Formea CM, Hoffman JM, Matey E, Peterson JF, Boyce RD. Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine. Cpt: Pharmacometrics & Systems Pharmacology. PMID 28109071 DOI: 10.1002/psp4.12173 |
0.365 |
|
| 2016 |
Brochhausen M, Empey PE, Schneider J, Hogan WR, Boyce RD. Adding evidence type representation to DIDEO. Ceur Workshop Proceedings. 1747. PMID 33139971 |
0.512 |
|
| 2016 |
Kane-Gill SL, Hanlon JT, Fine MJ, Perera S, Culley CM, Studenski SA, Nace DA, Boyce RD, Castle NG, Handler SM. Physician Perceptions of Consultant Pharmacist Services Associated with an Intervention for Adverse Drug Events in the Nursing Facility. The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists. 31: 708-720. PMID 28074750 DOI: 10.4140/Tcp.N.2016.708 |
0.39 |
|
| 2016 |
Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an Automated Knowledge Base for Identifying Drug Adverse Reactions. Journal of Biomedical Informatics. PMID 27993747 DOI: 10.1016/J.Jbi.2016.12.005 |
0.574 |
|
| 2016 |
Samwald M, Xu H, Blagec K, Empey PE, Malone DC, Ahmed SM, Ryan P, Hofer S, Boyce RD. Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available. Plos One. 11: e0164972. PMID 27764192 DOI: 10.1371/Journal.Pone.0164972 |
0.486 |
|
| 2016 |
Hochheiser H, Ning Y, Hernandez A, Horn JR, Jacobson R, Boyce RD. Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study. Jmir Research Protocols. 5: e40. PMID 27066806 DOI: 10.2196/resprot.5028 |
0.51 |
|
| 2016 |
Blagec K, Romagnoli KM, Boyce RD, Samwald M. Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study. Peerj. 4: e1671. PMID 26925317 DOI: 10.7717/Peerj.1671 |
0.429 |
|
| 2016 |
Romagnoli KM, Boyce RD, Empey PE, Adams S, Hochheiser H. Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements. International Journal of Medical Informatics. 86: 54-61. PMID 26725696 DOI: 10.1016/J.Ijmedinf.2015.11.015 |
0.333 |
|
| 2015 |
Ayvaz S, Horn J, Hassanzadeh O, Zhu Q, Stan J, Tatonetti NP, Vilar S, Brochhausen M, Samwald M, Rastegar-Mojarad M, Dumontier M, Boyce RD. Toward a complete dataset of drug-drug interaction information from publicly available sources. Journal of Biomedical Informatics. 55: 206-17. PMID 25917055 DOI: 10.1016/J.Jbi.2015.04.006 |
0.492 |
|
| 2015 |
Samwald M, Miñarro Giménez JA, Boyce RD, Freimuth RR, Adlassnig KP, Dumontier M. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies. Bmc Medical Informatics and Decision Making. 15: 12. PMID 25880555 DOI: 10.1186/S12911-015-0130-1 |
0.416 |
|
| 2015 |
Scheife RT, Hines LE, Boyce RD, Chung SP, Momper JD, Sommer CD, Abernethy DR, Horn JR, Sklar SJ, Wong SK, Jones G, Brown ML, Grizzle AJ, Comes S, Wilkins TL, et al. Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support. Drug Safety. 38: 197-206. PMID 25556085 DOI: 10.1007/S40264-014-0262-8 |
0.594 |
|
| 2015 |
Schneider J, Brochhausen M, Rosko S, Ciccarese P, Hogan WR, Malone D, Ning Y, Clark T, Boyce RD. Formalizing knowledge and evidence about potential drug-drug interactions Ceur Workshop Proceedings. 1428. |
0.532 |
|
| 2014 |
Brochhausen M, Schneider J, Malone D, Empey PE, Hogan WR, Boyce RD. Towards a foundational representation of potential drug-drug interaction knowledge. Ceur Workshop Proceedings. 1309: 16-31. PMID 33139970 |
0.538 |
|
| 2014 |
Ayvaz S, Zhu Q, Hochheiser H, Brochhausen M, Horn J, Dumontier M, Samwald M, Boyce RD. Drug-drug interaction data source survey and linking. Amia Joint Summits On Translational Science Proceedings Amia Summit On Translational Science. 2014: 16. PMID 25717393 |
0.504 |
|
| 2014 |
Boyce RD, Perera S, Nace DA, Culley CM, Handler SM. A survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferences. Applied Clinical Informatics. 5: 895-906. PMID 25589905 DOI: 10.4338/Aci-2014-06-Ra-0053 |
0.407 |
|
| 2014 |
Boyce RD, Ryan PB, Norén GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifirò G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, et al. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Safety. 37: 557-67. PMID 24985530 DOI: 10.1007/S40264-014-0189-0 |
0.565 |
|
| 2014 |
Miñarro-Giménez JA, Blagec K, Boyce RD, Adlassnig KP, Samwald M. An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care. Plos One. 9: e93769. PMID 24787444 DOI: 10.1371/Journal.Pone.0093769 |
0.449 |
|
| 2014 |
Brochhausen M, Schneider J, Malone D, Empey PE, Hogan WR, Boyce RD. Towards a foundational representation of potential drug-drug interaction knowledge Ceur Workshop Proceedings. 1309: 16-31. |
0.518 |
|
| 2014 |
Hernandez AM, Hochheiser H, Horn J, Crowley R, Boyce RD. Testing pre-annotation to help non-experts identify drug-drug interactions mentioned in drug product labeling Aaai Workshop - Technical Report. 14-15. |
0.499 |
|
| 2014 |
Schneider J, Ciccarese P, Clark T, Boyce RD. Using the micro publications ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base Ceur Workshop Proceedings. 1282: 60-70. |
0.515 |
|
| 2013 |
Hassanzadeh O, Zhu Q, Freimuth R, Boyce R. Extending the "web of drug identity" with knowledge extracted from United States product labels. Amia Joint Summits On Translational Science Proceedings Amia Summit On Translational Science. 2013: 64-8. PMID 24303301 |
0.304 |
|
| 2013 |
Boyce RD, Freimuth RR, Romagnoli KM, Pummer T, Hochheiser H, Empey PE. Toward semantic modeling of pharmacogenomic knowledge for clinical and translational decision support. Amia Joint Summits On Translational Science Proceedings Amia Summit On Translational Science. 2013: 28-32. PMID 24303292 |
0.39 |
|
| 2013 |
Handler SM, Boyce RD, Ligons FM, Perera S, Nace DA, Hochheiser H. Use and perceived benefits of mobile devices by physicians in preventing adverse drug events in the nursing home. Journal of the American Medical Directors Association. 14: 906-10. PMID 24094901 DOI: 10.1016/J.Jamda.2013.08.014 |
0.422 |
|
| 2013 |
Samwald M, Freimuth R, Luciano JS, Lin S, Powers RL, Marshall MS, Adlassnig KP, Dumontier M, Boyce RD. An RDF/OWL knowledge base for query answering and decision support in clinical pharmacogenetics. Studies in Health Technology and Informatics. 192: 539-42. PMID 23920613 DOI: 10.3233/978-1-61499-289-9-539 |
0.307 |
|
| 2013 |
Boyce RD, Horn JR, Hassanzadeh O, Waard Ad, Schneider J, Luciano JS, Rastegar-Mojarad M, Liakata M. Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness. Journal of Biomedical Semantics. 4: 5. PMID 23351881 DOI: 10.1186/2041-1480-4-5 |
0.582 |
|
| 2012 |
Boyce RD, Collins C, Clayton M, Kloke J, Horn JR. Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software. The Annals of Pharmacotherapy. 46: 1287-98. PMID 23032655 DOI: 10.1345/Aph.1R150 |
0.575 |
|
| 2012 |
Boyce RD, Handler SM, Karp JF, Hanlon JT. Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information. The American Journal of Geriatric Pharmacotherapy. 10: 139-50. PMID 22285509 DOI: 10.1016/J.Amjopharm.2012.01.001 |
0.507 |
|
| 2012 |
Marshall MS, Boyce R, Deus HF, Zhao J, Willighagen EL, Samwald M, Pichler E, Hajagos J, Prud'Hommeaux E, Stephens S. Emerging practices for mapping and linking life sciences data using RDF - A case series Journal of Web Semantics. 14: 2-13. DOI: 10.1016/J.Websem.2012.02.003 |
0.444 |
|
| 2011 |
Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM. Year in review: medication mishaps in the elderly. The American Journal of Geriatric Pharmacotherapy. 9: 1-10. PMID 21459304 DOI: 10.1016/J.Amjopharm.2011.01.003 |
0.355 |
|
| 2010 |
Marcum ZA, Handler SM, Boyce R, Gellad W, Hanlon JT. Medication misadventures in the elderly: a year in review. The American Journal of Geriatric Pharmacotherapy. 8: 77-83. PMID 20226395 DOI: 10.1016/J.Amjopharm.2010.02.002 |
0.428 |
|
| 2009 |
Boyce R, Collins C, Horn J, Kalet I. Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions. Journal of Biomedical Informatics. 42: 990-1003. PMID 19539050 DOI: 10.1016/J.Jbi.2009.05.010 |
0.7 |
|
| 2009 |
Boyce R, Collins C, Horn J, Kalet I. Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment. Journal of Biomedical Informatics. 42: 979-89. PMID 19435613 DOI: 10.1016/J.Jbi.2009.05.001 |
0.706 |
|
| 2007 |
Boyce RD, Collins C, Horn J, Kalet I. Modeling drug mechanism knowledge using evidence and truth maintenance. Ieee Transactions On Information Technology in Biomedicine : a Publication of the Ieee Engineering in Medicine and Biology Society. 11: 386-97. PMID 17674621 DOI: 10.1109/TITB.2007.890842 |
0.702 |
|
| 2005 |
Boyce R, Collins C, Horn J, Kalet IJ. Qualitative pharmacokinetic modeling of drugs. Amia ... Annual Symposium Proceedings / Amia Symposium. Amia Symposium. 71-5. PMID 16779004 |
0.699 |
|
| Show low-probability matches. |